Showing 51-56 of 56 results for "".
- Galderma's Dysport Celebrates 10 Years Since FDA Approvalhttps://modernaesthetics.com/news/dysport-celebrates-10-years-since-fda-approval/2471921/Galderma Laboratories’ Dysport (abobotulinumtoxinA) is ringing in its 10th birthday. To celebrate this milestone, Galderma is offering double points for Dysport aesthetic treatments registered in
- Evolus: Jeuveau FDA Cleared for Aesthetic Injectionhttps://modernaesthetics.com/news/evolus-jeuveau-fda-cleared-for-aesthetic-injection/2471954/The FDA has approved Jeuveau™ (prabotulinumtoxinA-xvfs), the lead product from Evolus, Inc., for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults. It will be available to physicians this sp
- Galderma Announces the Start of Six New Aesthetic Studieshttps://modernaesthetics.com/news/galderma-announces-the-start-of-six-new-aesthetic-studies/2472014/Galderma Laboratories, L.P. is initiating six new Phase III and IV U.S. aesthetic clinical trials. The six newly initiated studies include three pivotal trials evaluating XpresHAn Technology products; two studies for Dysport evaluating patient satisfaction and
- Mara Shorr, BS, CAC XIV, -, CAC, II, IXhttps://modernaesthetics.com/profiles/mara-shorr-bs-cac-xiv-cac-ii-ix/7vRerx/
- Jay Shorr, BA, MBM-C, CAC XIV, Managing Partner The Best Medical Business Solutions, AH, M.A.S., CAC I, II, IIIhttps://modernaesthetics.com/profiles/jay-shorr-ba-mbm-c-cac-xiv-managing-partner-the-best-medical-business-solutions-ah-mas-cac-i-ii-iii/Ld0PB4/
- Karan Lal, DO, MS, FAADhttps://modernaesthetics.com/profiles/karan-lal-do-ms-faad/L2YXnB/Originally from New York City, he grew up in Queens and attended Hunter Science High School in Manhattan. He graduated summa cum laude from the New York Institute of Technology, where he completed a rigorous seven-year accelerated combined medical program. He was selected to be an academic medical …
- Previous
- Next